GUTS Q3 2025 Earnings — Fractyl Health, Inc. Common Stock Revenue & Financial Results | Market Cap Arena

GUTSFractyl Health, Inc. Common Stock

$35M

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$290,000

Operating Income

-$23M

Net Income

-$46M

EPS (Diluted)

$-0.71

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$23M

Free Cash Flow

-$23M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$114M

Total Liabilities

$117M

Stockholders' Equity

-$3M

Cash & Equivalents

$78M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$14,000	-100.0%
Gross Profit	-$290,000	$7,000	-4242.9%
Operating Income	-$23M	-$24M	+4.6%
Net Income	-$46M	-$23M	-96.8%